These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16914099)

  • 1. Negative regulation of type I interferon signaling: facts and mechanisms.
    Coccia EM; Uzé G; Pellegrini S
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):77-87. PubMed ID: 16914099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interferon alfa signaling components in human alcoholic liver disease.
    Nguyen VA; Gao B
    Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.
    Malakhova OA; Kim KI; Luo JK; Zou W; Kumar KG; Fuchs SY; Shuai K; Zhang DE
    EMBO J; 2006 Jun; 25(11):2358-67. PubMed ID: 16710296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of type I interferon signaling in normal and malignant cells.
    Li Y; Srivastava KK; Platanias LC
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism.
    Lin RJ; Chang BL; Yu HP; Liao CL; Lin YL
    J Virol; 2006 Jun; 80(12):5908-18. PubMed ID: 16731929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity.
    Fenner JE; Starr R; Cornish AL; Zhang JG; Metcalf D; Schreiber RD; Sheehan K; Hilton DJ; Alexander WS; Hertzog PJ
    Nat Immunol; 2006 Jan; 7(1):33-9. PubMed ID: 16311601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of type-I interferon signal transduction.
    Uddin S; Platanias LC
    J Biochem Mol Biol; 2004 Nov; 37(6):635-41. PubMed ID: 15607020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
    Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
    J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JAK-STAT pathway at twenty.
    Stark GR; Darnell JE
    Immunity; 2012 Apr; 36(4):503-14. PubMed ID: 22520844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling.
    Prejean C; Colamonici OR
    Semin Cancer Biol; 2000 Apr; 10(2):83-92. PubMed ID: 10936059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic Science for the clinician 41: tails of cytokine receptor activation and control: JAKs, STATs, PIASs, and SOCSs.
    Sigal LH
    J Clin Rheumatol; 2006 Dec; 12(6):315-9. PubMed ID: 17149068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon.
    Eantuzzi L; Eid P; Malorni W; Rainaldi G; Gauzzi MC; Pellegrini S; Belardelli F; Gessani S
    Eur J Immunol; 1997 May; 27(5):1075-81. PubMed ID: 9174595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of interferon-induced Stat1 phosphorylation in activated T cells.
    Van De Wiele CJ; Marino JH; Whetsell ME; Vo SS; Masengale RM; Teague TK
    J Interferon Cytokine Res; 2004 Mar; 24(3):169-78. PubMed ID: 15035850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction by type I interferons.
    David M
    Biotechniques; 2002 Oct; Suppl():58-65. PubMed ID: 12395928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of porcine interferon-δ-related genes identified by genomic database screening.
    Zhao X; Cheng G; Jiao Y; Yan W; Liu M; Zheng Z
    J Interferon Cytokine Res; 2012 Aug; 32(8):378-85. PubMed ID: 22799504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
    Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
    Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses.
    Diamond MS
    J Interferon Cytokine Res; 2009 Sep; 29(9):521-30. PubMed ID: 19694536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.